Rhythm Pharmaceuticals (RYTM) Shareholder's Equity Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.61% |
| Dec 31, 2025 | -19.26% |
| Sep 30, 2025 | -19.11% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | -56.85% |
| Dec 31, 2024 | -57.55% |
| Sep 30, 2024 | -67.35% |
| Jun 30, 2024 | -51.82% |
| Mar 31, 2024 | -45.53% |
| Dec 31, 2023 | 0.64% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | -6.88% |
| Mar 31, 2023 | -4.60% |
| Dec 31, 2022 | -2.03% |
| Sep 30, 2022 | 23.55% |
| Jun 30, 2022 | 2.54% |
| Mar 31, 2022 | 2.26% |
| Dec 31, 2021 | 4.89% |
| Sep 30, 2021 | 6.12% |
| Jun 30, 2021 | 7.35% |
| Mar 31, 2021 | 41.78% |
| Dec 31, 2020 | 4.77% |
| Sep 30, 2020 | 79.65% |
| Dec 31, 2019 | 119.62% |